Early Transcatheter Mitral Valve Repair After Myocardial Infarction — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Early Transcatheter Mitral Valve Repair After Myocardial Infarction — Stella

Recruiting

Back to Acute Mitral Regurgitation trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(32 sites)

Israel

Emek Medical Center, Afula, Afula

Shaare Zedek Medical Center, Jerusalem, Jerusalen

Rabin Medical Center, Petah Tikva, Petah Tikva

Sheba Medical Center, Ramat Gan, Ramat Gan

Italy

Civil Hospital of Brescia, Brescia, Brescia

Key details

Sponsor

Fundación para la Investigación Biosanitaria del Principado de Asturias

Collaborators

Meditrial Europe Ltd.

Enrollment target

~250 participants

Started

December 2024

Primary completion

June 2027

Age range

18 Years – 99 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

View full record on ClinicalTrials.gov

Follow this trial

Get notified in plain English when this trial's status changes. No account required.